EUDA Health  Limited logo

EUDA Health Limited

EUDA | NASDAQ
Chart Builder DCF Calculator
$17.29
-$0.09 (-0.52%)
At close: Sep 22, 2026, 4:00 PM ET
$17.29
$0 (-0.03%)
After-hours: Sep 22, 2026, 7:30 PM ET

Market Data

Market Cap
$32.46M
Enterprise Value
$33.34M
Beta
0.59
Average Volume
23.01K
Shares Outstanding (Diluted)
1.86M
Shares Change YoY
1.66%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
VGG3142E1473

Price Performance

Price Change 1M
25.9%
Price Change 3M
17.1%
Price Change 6M
46.0%
Price Change YTD
-66.0%
Price Change 1Y
-32.5%
Price Change 3Y
-42.6%
Price Change 5Y
-91.3%
1M CAGR (ann.)
9.3%
1Y CAGR (ann.)
-23.1%
5Y CAGR (ann.)
N/A
All-Time CAGR
-39.6%

Valuation

PE Ratio
-6.54
Forward PE
19.50
PEG Ratio
0.08
Forward PEG
0.03
PS Ratio
2.66
Forward PS
N/A
PB Ratio
-7.35
P/FCF Ratio
-7.15
P/Adj. FCF Ratio
-7.15
P/OCF Ratio
-7.31
EV/Sales
2.84
EV/EBIT
-7.78
EV/EBITDA
-8.94
EV/FCF
-7.62
Earnings Yield
-15.3%
FCF Yield
-14.0%
Adj. FCF Yield
-14.0%

Financial Health

Net Debt
$1.86M
Total Debt
$2.4M
Cash & Short-Term Investments
$345.15K
Total Assets
$1.72M
Current Ratio
0.18
Quick Ratio
0.18
Debt / Equity Ratio
-0.56
Debt / EBITDA
-0.64
Debt / FCF
-0.55
OCF / Debt
-1.77
Interest Coverage
-11.74
Altman Z-Score
-44.61
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
41.7%
Operating Profit Margin
-36.4%
EBITDA Margin
-31.7%
Net Profit Margin
-40.5%
FCF Margin
-37.2%
Adj. FCF Margin
-37.2%
SBC / Revenue
0.0%
SBC Impact (per share)
N/A

Returns

Return on Assets
-277.4%
Return on Equity
119.6%
Return on Invested Capital
239.9%
Return on Capital Employed
104.0%
Return on Tangible Assets
-306.2%

Historical Growth (CAGR)

Revenue CAGR 3Y
5.2%
Revenue CAGR 5Y
-5.1%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
37.9%
EPS CAGR 5Y
21.3%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-72.2%
FCF CAGR 5Y
-37.6%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
1
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Mar 2, 2027
EPS Estimate (next Q)
$1.20
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
$17.62M
Revenue Growth Est (next Q)
836.7%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$2.75
Price Target Upside
-83.6%

Cash Flow

Operating Cash Flow
$-4.25M
Free Cash Flow
$-4.38M
Adj. Free Cash Flow
$-4.38M
FCF Per Share
-$2.35
OCF Per Share
-$2.29
OCF/S Ratio
-36.1%

Income Statement

Revenue
$11.76M
Gross Profit
$4.91M
Operating Income
$-4.28M
EBITDA
$-3.73M
Net Income
$-4.76M
EPS (Diluted)
-$2.56
Revenue / Employee
$95.6K
Profit / Employee
$-38.71K
Employees
123

© 2026 bestshares.com. All rights reserved.